Scarica l'app Stockscreener
33.16
5.50%
-1.93
Precedente Chiudi:
$35.09
Aprire:
$34.99
Volume 24 ore:
741.62K
Relative Volume:
3.42
Capitalizzazione di mercato:
$304.68M
Reddito:
$103.14M
Utile/perdita netta:
$-5.82M
Rapporto P/E:
-7.6184
EPS:
-4.3526
Flusso di cassa netto:
$2.14M
1 W Prestazione:
-5.45%
1M Prestazione:
-5.53%
6M Prestazione:
+67.64%
1 anno Prestazione:
+13.17%
Intervallo 1D:
$30.40
$34.99
Intervallo di 1 settimana:
$30.40
$35.52
Portata 52W:
$16.05
$35.52
Sanara Medtech Inc Stock (SMTI) Company Profile
Nome
Sanara Medtech Inc
Settore
Industria
Telefono
817-529-2300
Indirizzo
1200 SUMMIT AVE, FORT WORTH
Compare SMTI vs ISRG, BDX, RMD, ALC, MDLN
| Azioni | Prezzo | Cap. di mercato | Reddito | Reddito netto | Flusso di cassa | EPS |
|---|---|---|---|---|---|---|
SMTI
Sanara Medtech Inc
|
33.16 | 304.68M | 103.14M | -5.82M | 2.14M | -4.3526 |
ISRG
Intuitive Surgical Inc
|
426.70 | 150.74B | 11.03B | 3.16B | 3.22B | 8.7251 |
BDX
Becton Dickinson Co
|
191.75 | 52.23B | 21.37B | 1.41B | 3.07B | 3.9437 |
RMD
Resmed Inc
|
238.97 | 33.61B | 5.54B | 1.52B | 1.74B | 10.37 |
ALC
Alcon Inc
|
66.18 | 31.99B | 10.63B | 819.00M | 1.59B | 1.6577 |
MDLN
Medline Inc
|
35.96 | 31.55B | 29.14B | 1.07B | 1.05B | 1.1956 |
Sanara Medtech Inc Stock (SMTI) Upgrades & Downgrades
| Data | Azione | Analista | Modifica della valutazione |
|---|---|---|---|
| 2026-07-30 | Downgrade | H.C. Wainwright | Buy → Neutral |
| 2026-04-15 | Iniziato | Lake Street | Buy |
| 2025-03-26 | Reiterato | H.C. Wainwright | Buy |
| 2024-12-23 | Iniziato | H.C. Wainwright | Buy |
| 2022-05-20 | Ripresa | Cantor Fitzgerald | Overweight |
| 2021-06-30 | Iniziato | Cantor Fitzgerald | Overweight |
Mostra tutto
Sanara Medtech Inc Borsa (SMTI) Ultime notizie
A 30-day merger waiting period restarts as Sanara MedTech (SMTI) shareholders vote. - Stock Titan
Sanara MedTech Investor Alert: Kahn Swick & Foti, LLC Investigates Adequacy of Price and Process in Proposed Sale of Sanara MedTech Inc.SMTI - Business Wire
MIMEDX to Participate in Upcoming Investor Conferences - GlobeNewswire Inc.
Sanara MedTech Seeks Shareholder Approval for Merger With MiMedx - The Globe and Mail
Sanara MedTech Seeks Shareholder Approval for Merger With MiMedx - TipRanks
[DEFM14A] Sanara MedTech Inc. Merger Proxy Statement - stocktitan.net
Why (SMTI) Price Action Is Critical for Tactical Trading - Stock Traders Daily
Sanara Medtech Inc (SMTI) Key Financial Ratios – Valuation, Profitability & More - Value Research
Sanara MedTech (SMTI) Holds Steady at $34.57 as Traders Eye Resistance at $36.30ATR Trailing Stop - dars.gov.et
SMTI Stock Alert: Halper Sadeh LLC is Investigating Whether Sanar - The National Law Review
SMTI Stock Alert: Halper Sadeh LLC is Investigating Whether Sanara MedTech Inc. is Obtaining a Fair Price for its Shareholders - The Daily Tribune News
SMTI Stock Alert: Halper Sadeh LLC is Investigating Whether Sanara MedTech Inc. is Obtaining a Fair Price for its Shareholders - Business Wire
SMTI | Sanara MedTech Inc. Common FinancialsRevenue Breakdown - Quiver Quantitative
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Sanara MedTech, Inc.SMTI - Eastern Progress
Sanara MedTech (SMTI) agrees to MiMedx takeover, targeting year-end close - Stock Titan
Sanara MedTech Inc. (NASDAQ:SMTI) Short Interest Update - MarketBeat
Walleye Capital LLC Makes New $719,000 Investment in Sanara MedTech Inc. $SMTI - MarketBeat
SMTI Q1 2026 Earnings: Positive EPS Surprise Overcomes Expected LossOne-Time Gain Impact - vinanet.vn
Sanara MedTech (SMTI) Stock Stays Quiet As Profitability Meets Debt Scrutiny - Sahm
(SMTI) Movement Within Algorithmic Entry Frameworks - Stock Traders Daily
Sanara MedTech (SMTI) Stock Stays Quiet As Profitability Meets Debt Scrutiny - webull.com
Sanara Medtech earnings missed by $0.02, revenue fell short of estimates - Investing.com Canada
Sanara Medtech Inc reports results for the quarter ended June 30Earnings Summary - TradingView
Sanara MedTech Inc. (SMTI) Tops Q2 Earnings Estimates - Yahoo Finance
Sanara MedTech (NASDAQ:SMTI) Issues Quarterly Earnings Results, Misses Expectations By $0.03 EPS - MarketBeat
Sanara MedTech Q2 Results: Sales Rise 9% YoY, EPS Misses Estimate - scanx.trade
Sanara Medtech earnings missed by $0.02, revenue fell short of estimates - Investing.com
Sanara MedTech Inc. Q2 2026: Revenue $28.14M, EPS $(0.05) — 10-Q Summary - TradingView
Sanara MedTech (SMTI) grows H1 2026 revenue to $55.9M and trims loss - Stock Titan
MiMedx Group (SMTI partner) clarifies Sanara merger fees and $33 cash-plus-stock deal - Stock Titan
Form 8K Sanara Medtech Inc For: 11 August By Investing.com - Investing.com Nigeria
Sanara MedTech Corrects Termination Fees in Merger Deal with MiMedx - Kalkine Media
Form 8K Sanara Medtech Inc For: 11 August By Investing.com - Investing.com South Africa
Sanara MedTech Inc. (SMTI) Releases Q2 2026 Earnings: Revenue Rises 8.9% - Quiver Quantitative
Sanara MedTech (SMTI) sets $33 cash plus MiMedx stock merger terms and corrects fees - Stock Titan
Sanara MedTech Inc. Reports Second Quarter 2026 Financial Results (Unaudited) - The Manila Times
Form 8K Sanara Medtech Inc For: 11 August By Investing.com - Investing.com India
Sanara MedTech Q2 revenue rises on soft-tissue product growth - TradingView
Form 8K Sanara Medtech Inc For: 11 August By Investing.com - Investing.com Canada
Sanara MedTech (SMTI) grows revenue, posts Q2 loss amid pending MIMEDX deal - Stock Titan
Sanara MedTech Inc. Reports Second Quarter 2026 Financial Results (Unaudited) - Yahoo Finance
Sanara MedTech (SMTI) sets $33 cash plus MiMedx stock per share in merger - Stock Titan
Sanara MedTech, Inc. (SMTI) Investigation: Bronstein, Gewirtz & G - The National Law Review
Sanara Medtech Inc expected to post a loss of 2 cents a shareEarnings Preview - TradingView
Sanara MedTech Inc. (NASDAQ:SMTI) Receives Consensus Recommendation of "Reduce" from Analysts - MarketBeat
Sanara MedTech, Inc. (SMTI) Investigation: Bronstein, Gewirtz & G - The National Law Review
Bronstein, Gewirtz & Grossman, LLC Is Investigating Sanara MedTec - The National Law Review
Sanara MedTech (SMTI) Expected to Post Earnings on Wednesday - MarketBeat
Bronstein, Gewirtz & Grossman, LLC Encourages Sanara MedTech Inc - The National Law Review
Bronstein, Gewirtz & Grossman, LLC Encourages Sanara MedTech, Inc - The National Law Review
Sanara Medtech Inc Azioni (SMTI) Dati Finanziari
Reddito
Reddito netto
Flusso di cassa
EPS
2.79%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):